Skip to main content

Table 1 Patient characteristics (n = 99)

From: Risk of postoperative nausea and vomiting in hip and knee arthroplasty: a prospective cohort study after spinal anaesthesia including intrathecal morphine

 

Value

Gender, female sex

42 (42%)

Age, years

67 (37–87)

BMI, m2kg−1

28 (19–43)

ASA-class

 1

26 (26%)

 2

60 (61%)

 3

13 (13%)

Smokers

1 (1%)

History of motion sickness

19 (19%)

Previous PONV

19 (19%)

Preoperative treatment with opioids

12 (12%)

COX-2 inhibitor in premedication

9 (9%)

Apfel-score

 0–1

0 (0%)

 2

44 (44%)

 3

35 (35%)

 4

20 (20%)

Hip prosthesis surgery, numbers

78 (79%)

Knee prosthesis surgery, numbers

21 (21%)

Spinal anaesthesia combined with intrathecal morphine and clonidine

99 (100%)

Duration of anaesthesia, minutes

170 (105–336)

Duration of surgery, minutes

95 (57–256)

PONV prophylaxis

 Betamethasone

93 (94%)

 Ondansetron

54 (55%)

 Droperidol

20 (20%)

Number of prophylaxes given

 0

3 (3%)

 1

45 (45%)

 2

31 (31%)

 3

20 (20%)

Rescue antiemetics until noon Day 1

27 (27%)

Gabapentin included in postoperative medication

36 (36%)

  1. Values are presented as numeric values (% of total) or median (SD). ASA American Society of Anaesthesiologists Classification, PONV postoperative nausea and vomiting, BMI body mass index. PONV, number of prophylaxis given: Of those receiving only 1 prophylactic drug, 42 patients received betamethasone and 3 received ondansetron. For those given two prophylaxis, all received betamethasone and ondansetron. No missing data except BMI of one patient